The Agno Priorities

At Agno Pharma, we prioritize flexibility and customer-centric dosage forms, accommodating projects that other CMOs may decline due to batch size or complexity. Our 3,000 sq. ft. of flexible cleanroom space allows us to adapt to varying project needs, from straightforward processes to intricate formulations requiring specialized equipment. We collaborate closely with our clients to ensure their specific requirements are met, leveraging our expertise to navigate the challenges of commercial manufacturing effectively.

Our facility features advanced capabilities tailored for sterile and complex drug products, such as ISO 5 suites for aseptic fill/finish and a dedicated 120 sq. ft. commercial lyophilizer equipped for clean-in-place operations. We excel in particle size reduction technologies, including nanomilling under aseptic conditions at a commercial scale, a unique offering in the industry. Our fill-finish operations handle both small molecule drug products and biologics across various container types, ensuring comprehensive support from development to commercialization.

Agno Pharma is committed to delivering high-quality outcomes and supporting our clients through every stage of their commercial manufacturing journey. With a focus on innovation, flexibility, and customer satisfaction, we provide the critical manufacturing solutions necessary to bring your drug product successfully to market.